{
  "id": "602c28551cb411341a000123",
  "type": "yesno",
  "question": "Has AZD9668 been tested in clinical trials?",
  "ideal_answer": "Yes, AZD9668 has been tested in clinical trials.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22458939",
    "http://www.ncbi.nlm.nih.gov/pubmed/26043724"
  ],
  "snippets": [
    {
      "text": "Efficacy, safety and tolerability of AZD9668 (5, 20 and 60 mg bid) were compared with placebo in a randomised, double-blind, placebo-controlled, 12-week, Phase IIb trial (NCT00949975: approved by an Investigational Review Board), in patients with symptomatic COPD receiving maintenance tiotropium. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22458939",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22458939",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}